Pulmonology
News from the FDA/CDC
THC use reported in majority of vaping-related illnesses
“THC-containing products are playing an important role in this outbreak [but] no single compound or ingredient has emerged as the cause.”
News
Opioids, benzodiazepines carry greater risk of COPD-related hospitalization
The risk of hospitalization because of respiratory events for patients with COPD was especially high when opioid and benzodiazepine medications...
News
ACIP approves child and adolescent vaccination schedule for 2020
Minor changes in wording and design to child and adolescent ACIP vaccination schedule match updates to adult schedule.
News from the FDA/CDC
Vaping-linked injuries top 1,600 cases
Thirty-four deaths have now been confirmed.
News
ACIP approves 2020 adult vaccination schedule
Updates to ACIP adult vaccination schedule include language on shared clinical decision making.
News
ACIP plans flu review for older adults
Work group will address issues of which flu vaccine options may be best for seniors.
News
ACIP recommends two options for pertussis vaccination
Updated language allows use of either Tdap or Td for pertussis booster, prophylaxis, and catch-up immunization, according to ACIP recommendations...
News from the FDA/CDC
CDC: Don’t vape, especially THC
Conference Coverage
Recent COPD exacerbation did not affect aclidinium’s efficacy in high-risk patients
NEW ORLEANS – A history of recent exacerbations didn’t significantly affect the safety or efficacy of aclidinium bromide in patients with moderate...
News from the FDA/CDC
FDA approves Trikafta for treatment of cystic fibrosis
This drug makes treatment available to most cystic fibrosis patients, including adolescents.